New Findings in Cleavage Sites Variability across Groups, Subtypes and Recombinants of Human Immunodeficiency Virus Type 1-Reference-Cited by-同舟云学术

New Findings in Cleavage Sites Variability across Groups, Subtypes and Recombinants of Human Immunodeficiency Virus Type 1

Published:2014-02-07 Issue:2 Volume:9 Page:e88099
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Torrecilla Esther,Llácer Delicado Teresa,Holguín África

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Swanstrom R, Wills J (1997) Retroviral gene expression. II. Synthesis, processing, and assembly of viral proteins. In: Coffin JM, Hughes SH, Varmus HE, editors. Retroviruses. New York: Cold Spring Harbor Laboratory. pp. 263–334.

2. Cleavage of HIV-1 proteinase from the N-terminally adjacent p6* protein is essential for efficient Gag polyprotein processing and viral infectivity;U Tessmer;J Virol,1998

3. Variability at HIV-1 subtype C protease cleavage sites: an indication of viral fitness?;T de Oliveira;J Virol,2003

4. HIV type 1 Gag as a target for antiviral therapy;AA Waheed;AIDS Res Hum Retroviruses,2012

5. Human immunodeficiency virus Gag and protease: partners in resistance;A Fun;Retrovirology,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Diversity and Low Therapeutic Impact of Variant-Specific Markers in HIV-1 Pol Proteins;Frontiers in Microbiology;2022-07-14

2. HIV Capsid Protein Genetic Diversity Across HIV-1 Variants and Impact on New Capsid-Inhibitor Lenacapavir;Frontiers in Microbiology;2022-04-12

3. Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria;Journal of Antimicrobial Chemotherapy;2021-11-06

4. Role of the Matrix-Capsid Cleavage Site Polymorphism S124V of HIV-1 Sub-subtype A2 in Gag Polyprotein Processing;2020-11-15

5. Gag-protease coevolution shapes the outcome of lopinavir-inclusive treatment regimens in chronically infected HIV-1 subtype C patients;Bioinformatics;2019-02-12